Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Lipid Research
|
December 31, 1998
In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARalpha-deficient mice
F Guéraud, J Alary, P Costet, et al.
The Biochemical Journal
|
August 4, 2001
Purification and characterization of a glutathione S-transferase Omega in pig: evidence for two distinct organ-specific transcripts
P Rouimi, P Anglade, A Benzekri, et al.
Experimental Eye Research
|
September 21, 2000
Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells
B Rousseau, D Dubayle, F Sennlaub, et al.
Toxicology Letters
|
February 18, 1999
Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes
T Pineau, P Costet, O Puel, et al.
Environmental Toxicology and Pharmacology
|
July 26, 2011
CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines
L Gervot, V Carrière, P Costet, et al.
FEBS Letters
|
December 5, 1994
Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7
V Carrière, T Lesuffleur, A Barbat, et al.
Toxicology Letters
|
October 17, 1998
Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway
A D Edgar, C Tomkiewicz, P Costet, et al.
The Biochemical Journal
|
April 4, 2001
Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine
H Poirier, I Niot, M C Monnot, et al.
Genomics
|
November 30, 2005
A knock-in mouse model of congenital erythropoietic porphyria
C Ged, M Mendez, E Robert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 11, 2001
Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
E Richard, M Mendez, F Mazurier, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Lipid Research
|
December 31, 1998
In vivo involvement of cytochrome P450 4A family in the oxidative metabolism of the lipid peroxidation product trans-4-hydroxy-2-nonenal, using PPARalpha-deficient mice
F Guéraud, J Alary, P Costet, et al.
The Biochemical Journal
|
August 4, 2001
Purification and characterization of a glutathione S-transferase Omega in pig: evidence for two distinct organ-specific transcripts
P Rouimi, P Anglade, A Benzekri, et al.
Experimental Eye Research
|
September 21, 2000
Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells
B Rousseau, D Dubayle, F Sennlaub, et al.
Toxicology Letters
|
February 18, 1999
Knockout animals in toxicology: assessment of toxin bioactivation pathways using mice deficient in xenobiotic metabolizing enzymes
T Pineau, P Costet, O Puel, et al.
Environmental Toxicology and Pharmacology
|
July 26, 2011
CYP3A5 is the major cytochrome P450 3A expressed in human colon and colonic cell lines
L Gervot, V Carrière, P Costet, et al.
FEBS Letters
|
December 5, 1994
Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7
V Carrière, T Lesuffleur, A Barbat, et al.
Toxicology Letters
|
October 17, 1998
Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway
A D Edgar, C Tomkiewicz, P Costet, et al.
The Biochemical Journal
|
April 4, 2001
Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine
H Poirier, I Niot, M C Monnot, et al.
Genomics
|
November 30, 2005
A knock-in mouse model of congenital erythropoietic porphyria
C Ged, M Mendez, E Robert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 11, 2001
Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
E Richard, M Mendez, F Mazurier, et al.
Page
of 3